CAPNOR
CAPNOR and the 25 companies it controls according to the LEI register and the annual accounts: the structure, the figures, each company's health and where the risk sits.
Sum of the filed annual accounts of 24 of the 25 Belgian companies (fiscal years 2024-2025). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.
Group risk
How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.
- The parent itself: CAPNOR, fair (51/100).
- 5 companies with negative equity: PHARMACLIC ASSETS (-€992,121), Pharmacies by Medi-Market Group (-€656,748), Parapharmacity (-€176,527), Capnor Asset Management (-€129,438), Apotheek by Medi-Market Group - Zemst (-€111,208).
- 9 companies with a loss in the latest year: MEDI-SUPPLY INTERNET (-€815,681), CAPNOR I MidCo (-€367,595), Capnor Asset Management (-€129,867), PHARMACLIC ASSETS (-€90,908), Medicare-Market Online Services (-€76,463), Parapharmacity (-€11,676) and 3 more.
- 10 companies no longer active in the register: Apotheek by Medi-Market Group - Gent, Apotheek by Medi-Market Group - Schoten, Apotheek by Medi-Market Group - Zemst, Medi-Market Mons Grand Pré, Parapharmacity, Pharmacie by Medi-Market Group - Bruxelles Docks and 4 more.
- 32.7% of the added-up total assets sits in one company: Medi-Market Group.
- 47.5% of the added-up total assets sits at companies with an elevated or high risk.
Group structure
Who consolidates whom according to the LEI register, completed with who holds more than half of the shares according to the annual accounts. Both mean control.
- CAPNOR6 subsidiariesFair · 51€19.9m €10,000 2024
- Elevated · 42€7.3m -€129,438 2025
- No verdict€1,841 €918 2025
- No verdict€1,806 €870 2025
- Elevated · 39€22.5m €6,103 2024
- CAPNOR I1 subsidiaryNo verdict€34.9m €614,257 2024
- Elevated · 45€67.1m €10.7m 2024
- CAPNOR II1 subsidiaryFair · 47€158.7m €37.0m 2024
- CAPNOR II MidCo1 subsidiaryNo verdictno figures
- Medi-Market Group6 subsidiariesNo verdict€351.9m €37.6m 2025
- Elevated · 25€171.3m €11.5m 2025
- Elevated · 31€185.5m €682,578 2025
- Elevated · 42€7.2m €787,748 2025
- Elevated · 29€20.4m -€656,748 2025
- PHARMACLIC ASSETS10 subsidiariesElevated · 43€13.6m -€992,121 2024
- Elevated€384,106 €117,999 2025
- Elevated€2.0m €1.9m 2025
- Elevated€609,724 -€111,208 2025
- Elevated€340,363 €156,356 2025
- Elevated€2.8m -€176,527 2025
- Elevated€923,448 €21,011 2025
- Elevated€2.6m €1.2m 2025
- Elevated€5.0m €890,124 2025
- Elevated€298,329 €145,653 2025
- Elevated€2.1m €1.8m 2025
- MEDI-MARKET ITALIA S.R.L.
High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.
Shared directors
Who sits on the boards of several group companies. This is where control over the group sits in practice.
-
4Medi-Market Groupgroup company
Events in the group
Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.
-
Medi-Market Group SA reappointed as director
-
Medi-Market Group SA reappointed as director
-
Medi-Market Group SA reappointed as director
-
Medi-Market Group SA reappointed as director
-
Share cancellation
-
2 directors resigning
-
Share cancellation
-
Pharmacie by Medi-Market Group - Korbeek-Lo resigns as director
-
Share cancellation
-
20 directors resigning
-
Medi-Market Mons Grand Pré resigns as director
-
Share cancellation
-
Share cancellation
-
3 directors resigning
-
2 directors resigning
-
Pharmacie by Medi-Market Group - Bruxelles Docks resigns as director
-
Share cancellation
-
3 directors resigning
-
Share cancellation
-
2 directors resigning
What is my exposure to this group?
The companies of this group you keep in your lists or follow, seen together.
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Where do these figures come from?
Completed with the annual accounts: a company of which another Belgian company holds more than half of the shares, by the list of holdings or the shareholder structure in its accounts, stands under that company, with the share. The register of ultimate beneficial owners (UBO) is not public.
The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.
The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.
Updated on 28-09-2026